Study on gram-negative bacterial infections
Part of Infections clinical trials.
This study looks at infections caused by gram-negative bacteria (a type of bacteria that can cause serious illness). It aims to learn more about these infections and how to treat them, which might help improve care for patients with such infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must agree to take part in the study.
- You cannot be in the intensive care unit (ICU) for less than 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
This study tests a careful antibiotic-use program for patients with a bloodstream infection caused by a group of bacteria called Enterobacterales. The goal is to use the right antibiotics for the right amount of time. It may help you get better treatment with fewer side effects.
This study is for people diagnosed with serious bacterial infections, specifically those caused by certain bacteria (pneumococcus, meningococcus, or haemophilus influenzae type b) that have spread throughout the body. The goal is to learn more about these infections and improve care.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
This study looks at how well beta-lactam antibiotics (a common type of antibiotic) work in people being treated for infections at Imperial College NHS Trust. The information may help doctors make better dosing decisions.
This study is looking at how well two strong antibiotics (ceftazidime/avibactam and cefiderocol) work, with or without another drug called fosfomycin, for treating tough Gram-negative infections. It aims to help doctors understand the best way to use these medicines.
Hear when a new Multi-resistant Gram-negative Bacteria Cause Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.